Tue, November 5, 2019
Mon, November 4, 2019
Fri, November 1, 2019
Thu, October 31, 2019
Wed, October 30, 2019
Tue, October 29, 2019
Mon, October 28, 2019
Fri, October 25, 2019
Thu, October 24, 2019
Wed, October 23, 2019

Mohit Bansal Maintained (BMRN) at Strong Buy with Decreased Target to $95 on, Oct 30th, 2019

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-decreased-target-to-95-on-oct-30th-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

- Click to Lock Slider
Mohit Bansal of Citigroup, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Decreased Target from $120 to $95 on, Oct 30th, 2019.

Mohit has made no other calls on BMRN in the last 4 months.



There are 3 other peers that have a rating on BMRN. Out of the 3 peers that are also analyzing BMRN, 1 agrees with Mohit's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gena Wang of "Barclays" Maintained at Hold with Decreased Target to $86 on, Thursday, October 24th, 2019


These are the ratings of the 2 analyists that currently disagree with Mohit


  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $108 on, Monday, October 28th, 2019
  • Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $152 on, Friday, October 25th, 2019